Hubbry Logo
PinocytosisPinocytosisMain
Open search
Pinocytosis
Community hub
Pinocytosis
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Pinocytosis
Pinocytosis
Pinocytosis
View on Wikipedia
from Wikipedia
Pinocytosis

In cellular biology, pinocytosis, otherwise known as fluid endocytosis and bulk-phase pinocytosis, is a mode of endocytosis in which small molecules dissolved in extracellular fluid are brought into the cell through an invagination of the cell membrane, resulting in their containment within a small vesicle inside the cell. These pinocytotic vesicles then typically fuse with early endosomes to hydrolyze (break down) the particles.[citation needed]

Pinocytosis is variably subdivided into categories depending on the molecular mechanism and the fate of the internalized molecules.

Function

[edit]

In humans, this process occurs primarily for absorption of fat droplets. In endocytosis the cell plasma membrane extends and folds around desired extracellular material, forming a pouch that pinches off creating an internalized vesicle. The invaginated pinocytosis vesicles are much smaller than those generated by phagocytosis. The vesicles eventually fuse with the lysosome, whereupon the vesicle contents are digested.[1] Pinocytosis involves a considerable investment of cellular energy in the form of ATP.[1]

Pinocytosis and ATP

[edit]

Pinocytosis is used primarily for clearing extracellular fluids (ECF) and as part of immune surveillance.[2] In contrast to phagocytosis, it generates very small amounts of ATP from the wastes of alternative substances such as lipids (fat)[citation needed]. Unlike receptor-mediated endocytosis, pinocytosis is nonspecific in the substances that it does transport: the cell takes in surrounding fluids, including all solutes present.[1]

Etymology and pronunciation

[edit]

The word pinocytosis (/ˌpɪnəsaɪˈtoʊsɪs, ˌpaɪ-, -noʊ-, -sə-/[3][4][5]) uses combining forms of pino- + cyto- + -osis, all Neo-Latin from Greek, reflecting píno, to drink, and cytosis. The term was proposed by W. H. Lewis in 1931.[6]

Non-specific, adsorptive pinocytosis

[edit]

Non-specific, adsorptive pinocytosis is a form of endocytosis, a process in which small particles are taken in by a cell by splitting off small vesicles from the cell membrane.[7] Cationic proteins bind to the negative cell surface and are taken up via the clathrin-mediated system, thus the uptake is intermediate between receptor-mediated endocytosis and non-specific, non-adsorptive pinocytosis. The clathrin-coated pits occupy about 2% of the surface area of the cell and only last about a minute, with an estimated 2500 leaving the average cell surface each minute. The clathrin coats are lost almost immediately, and the membrane is subsequently recycled to the cell surface.

Macropinocytosis

[edit]

Macropinocytosis is a clathrin-independent endocytic mechanism that can be activated in practically all animal cells, resulting in uptake. In most cell types, it does not occur continuously but rather is induced for a limited time in response to cell-surface receptor activation by specific cargoes, including growth factors, ligands of integrins, and apoptotic cell remnants. These ligands activate a complex signaling pathway, resulting in a change in actin dynamics and the formation of cell-surface protrusions of filopodia and lamellopodia, commonly called ruffles. When ruffles collapse back onto the membrane, large fluid-filled endocytic vesicles form called macropinosomes, which can transiently increase the bulk fluid uptake of a cell by up to tenfold. Macropinocytosis is a solely degradative pathway: macropinosomes acidify and then fuse with late endosomes or endolysosomes, without recycling their cargo back to the plasma membrane.[8]

Some bacteria and viruses have evolved to induce macropinocytosis as a mechanism for entering host cells. Some of these can stop the degradation processes in order to survive inside the macropinosome, which may transform into smaller and long-lasting vacuoles containing the viruses or bacteria (some of which may replicate inside), or simply escape through the wall of the macropinosome when inside. For example, the gut pathogen Salmonella typhimurium injects toxins into the host cell in order to induce macropinocytosis as a form of uptake, inhibits the degradation of the macropinosome, and forms a salmonella-containing vacuole, or SCV, wherein it can replicate.[9]

Inhibitors

[edit]

See also

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Pinocytosis

View on Grokipedia
from Grokipedia
Pinocytosis is a fundamental cellular process in which eukaryotic cells continuously internalize and its dissolved solutes through the formation of small membrane-bound vesicles, a mechanism known as "cell drinking." This non-selective form of typically produces vesicles approximately 100 nm in diameter and occurs constitutively in most cell types, enabling the uptake of , ions, nutrients, and other small molecules from the surrounding environment. The process begins with the of the plasma membrane, often at clathrin-coated pits, where the membrane curves inward and pinches off to form a coated vesicle within about one minute; these vesicles then rapidly shed their coats and fuse with early endosomes for further sorting and processing. Pinocytosis can also proceed via caveolae, flask-shaped invaginations rich in and that involve the protein caveolin, though this pathway is less well-characterized and may contribute to specific functions like in endothelial cells. Unlike , which targets specific ligands, pinocytosis is largely indiscriminate for fluid-phase uptake, with rates varying by —for instance, macrophages can internalize up to 25% of their cell volume per hour, while fibroblasts process about 1% per minute—highlighting its role in maintaining membrane dynamics and volume regulation. In physiological contexts, pinocytosis facilitates nutrient absorption, such as in intestinal epithelial cells where it aids in the of solutes and small molecules across the barrier, and supports immune functions in macrophages by enabling accumulation and sensing through fluid-phase sampling. It also plays a critical role in cellular by recycling plasma membrane components via , preventing net loss during ongoing internalization, and has implications in , including delivery for therapeutics and aberrant in diseases like . Overall, pinocytosis exemplifies the dynamic interplay between the cell and its microenvironment, underpinning essential processes from development to disease.

Definition and Fundamentals

Definition

Pinocytosis is a fundamental mode of in which eukaryotic cells internalize (ECF) along with its dissolved small molecules and solutes through the formation of membrane-bound vesicles. This process involves the of the plasma membrane to engulf portions of the ECF, forming vesicles of varying sizes depending on the subtype—typically 100 nm to 250 nm for small vesicle forms like fluid-phase micropinocytosis, and 0.2–5 μm for macropinocytosis—which then detach into the for further processing. Unlike , pinocytosis is generally non-specific, allowing the uptake of bulk fluid without targeting particular ligands. The term pinocytosis, often translated as "cell drinking," emphasizes its role in fluid ingestion, distinguishing it from , which involves the engulfment of larger solid particles. It specifically facilitates the incorporation of ECF components such as ions, nutrients, and soluble proteins into the cell without the need for prior binding to surface receptors. Synonyms for this process include fluid-phase and bulk-phase pinocytosis, highlighting its indiscriminate nature in sampling the extracellular environment. Pinocytosis occurs in nearly all eukaryotic cells as a constitutive process essential for maintaining , nutrient acquisition, and membrane turnover. It is particularly active in endothelial cells, where it supports and solute exchange; in epithelial cells, aiding in and absorption; and in immune cells such as macrophages, contributing to and pathogen sampling. This widespread prevalence underscores pinocytosis as a basal cellular activity, with rates varying by but collectively enabling the continuous renewal of endolysosomal compartments.

Key Characteristics

Pinocytosis is characterized by the formation of membrane-bound vesicles, typically measuring 100-200 nm in diameter for small vesicle forms, though macropinocytosis can produce much larger vesicles up to 5 μm; this contrasts with phagosomes formed during , which engulf solid particles and often exceed 0.5 μm, with the primary distinction being fluid versus solid cargo rather than size alone. This modest vesicle size in many cases enables the process to handle dissolved substances rather than solid particles, facilitating a subtle and efficient mode of uptake. A defining feature of pinocytosis, particularly in its fluid-phase form, is its non-selective nature, where the uptake of solutes occurs in proportion to their concentration in the (ECF), without reliance on specific receptors for most molecules. This bulk-phase ingestion allows cells to indiscriminately sample the ECF, incorporating nutrients, ions, and signaling molecules as they are present in the surrounding environment. In many cell types, pinocytosis operates as a continuous, constitutive process, often powered by to drive and vesicle . For instance, in macrophages, this results in the internalization of extracellular fluid equivalent to about 0.43% of the cell volume per minute, or roughly 26% per hour, alongside recycling the equivalent of the entire plasma surface area every 30 minutes. Pinocytosis differs fundamentally from , which targets large particles using actin-driven pseudopod extensions to form spacious phagosomes, and from , which selectively binds specific ligands via clathrin-coated pits to concentrate cargo in smaller, targeted vesicles.

Nomenclature and History

Etymology and Pronunciation

The term pinocytosis is derived from the Greek roots pino- (πίνω), meaning "to drink," combined with kytos (κύτος), meaning "cell," and the suffix -osis, denoting a or condition; this etymology reflects the analogy to a cell "drinking" extracellular fluid, in contrast to , or "cell eating." The word was coined by American cytologist Warren H. Lewis in 1931, following his observations of fluid droplet ingestion in cultured macrophages, marking its first documented use in to distinguish this mechanism from solid particle engulfment. In English, pinocytosis is commonly pronounced as /ˌpɪnəsaɪˈtoʊsɪs/ (pin-uh-sy-TOH-sis) in or /ˌpɪnəʊsaɪˈtəʊsɪs/ (pin-oh-sy-TOH-sis) in , with the primary stress on the "to" and secondary stress on the first . Variations may occur, such as /ˌpaɪnoʊsaɪˈtoʊsɪs/, but the emphasis consistently falls on the antepenultimate to align with the Greek-derived rhythm. Historically, alternative terms like "fluid endocytosis" or "bulk-phase endocytosis" have been adopted to emphasize the non-specific uptake of soluble substances in extracellular fluid, gaining prominence in later literature to integrate pinocytosis within the broader category of endocytic processes. These synonyms highlight the term's evolution from a descriptive analogy to a standardized concept in cell biology.

Historical Discovery

The discovery of pinocytosis traces its roots to the late 19th century, building upon Élie Metchnikoff's seminal observation of phagocytosis in 1882, where he described how certain cells engulf solid particles as a defense mechanism. Decades later, in 1931, American anatomist Warren H. Lewis provided the first detailed description of pinocytosis while studying macrophages in tissue culture using time-lapse cinematography. Lewis observed dynamic membrane ruffling and the formation of small fluid-filled droplets that pinched off from the cell surface, forming intracellular vesicles—a process he likened to "drinking by cells." He coined the term "pinocytosis," derived from the Greek words "pinos" (to drink) and "kytos" (cell), to distinguish this fluid uptake from the particle ingestion of phagocytosis. This initial work was published in the Bulletin of the Johns Hopkins Hospital, marking the phenomenon's formal introduction to the scientific community. Lewis's observations were vividly captured in early motion pictures, including a notable 1936 film titled Pinocytosis: Drinking by Cells, which demonstrated the real-time formation and internalization of vesicles in cultured cells such as macrophages and sarcoma cells. These films, produced using innovative phase-contrast microscopy techniques, allowed researchers to visualize the process's kinetics and morphology, highlighting its prevalence in various cell types beyond immune cells. By the mid-20th century, Lewis and collaborators had extended these studies to malignant cells, noting pinocytosis's role in their active surface dynamics, further solidifying its recognition as a ubiquitous cellular activity. The 1960s and 1970s marked a pivotal evolution in understanding pinocytosis, as the advent of electron microscopy enabled ultrastructural visualization and its integration into the broader framework of endocytic pathways. Pioneering studies, such as those by Brandt and Pappas in 1960 on amoebae, used electron microscopy to trace the attachment of extracellular markers like to the cell surface, followed by membrane invagination and vesicle formation during pinocytosis. This work, published in the Journal of Cell Biology, provided definitive evidence of the process's vesicular nature and its distinction from other uptake mechanisms. Subsequent research in mammalian cells during the , leveraging improved fixation and staining techniques, confirmed pinocytosis as a constitutive endocytic route, shifting perceptions from mere descriptive curiosity to a fundamental cellular process.

Types of Pinocytosis

Fluid-Phase Pinocytosis

Fluid-phase pinocytosis represents a constitutive, receptor-independent form of characterized by the non-specific engulfment of and dissolved solutes into small, uncoated vesicles typically measuring around 100 nm in diameter. This process allows cells to sample their surrounding environment indiscriminately, internalizing extracellular components in proportion to their concentration without requiring prior binding to the plasma . Unlike receptor-mediated pathways, it does not involve selective accumulation of ligands at specific sites, ensuring bulk uptake of the phase. The mechanism involves random invaginations of the plasma membrane that form transient pockets, which pinch off to generate vesicles containing ECF and solutes; this uptake is linearly dependent on solute concentration and occurs continuously in most eukaryotic cells. In intestinal epithelial cells, for instance, fluid-phase pinocytosis enables the non-selective sampling of luminal contents, contributing to basic cellular . The process is clathrin-independent in many cases, relying instead on alternative endocytic routes such as those mediated by or other regulators to facilitate vesicle scission. Quantitative assessments reveal that in actively endocytosing cells like fibroblasts, fluid-phase pinocytosis internalizes approximately 1% of the plasma membrane surface area per minute, highlighting its efficiency in membrane turnover. Experimental studies often employ inert tracers such as fluorescein-labeled or to quantify this activity in fibroblasts, where uptake rates directly correlate with fluid volume internalized, providing a reliable model for non-specific .

Adsorptive Pinocytosis

Adsorptive pinocytosis is a form of in which extracellular solutes, particularly polycations, bind to the plasma membrane through electrostatic or hydrophobic interactions prior to internalization into vesicles. This process enhances uptake efficiency compared to fluid-phase pinocytosis by concentrating bound solutes at the membrane surface. Unlike , adsorptive pinocytosis does not involve specific ligand-receptor recognition but relies instead on nonspecific charge-based adsorption to negatively charged components of the plasma membrane, such as sialo-glycoconjugates and proteoglycans. Vesicle formation in adsorptive pinocytosis typically occurs through of the plasma membrane at clathrin-coated pits, generating coated vesicles, though it can also involve caveolae depending on the and solute. The adsorbed solutes are thereby concentrated within the resulting vesicles by 10-100 fold relative to their levels in the , due to the saturable binding capacity of the membrane sites. This concentration facilitates efficient capture and transport, with the process being saturable, exhibiting maximum binding capacities on the order of several nanomoles per milligram of . Key examples of adsorptive pinocytosis include the uptake of cationic and poly-L-lysine in endothelial cells, where these polycations bind to anionic membrane sites and are internalized into vesicles for potential . Cationic , a positively charged tracer, has been widely used to visualize these interactions and demonstrate binding to the luminal surface of capillary endothelium. Similarly, poly-L-lysine promotes membrane adsorption and vesicle formation in various cell types, highlighting the role of charge in driving the process. In biological contexts, adsorptive pinocytosis plays a significant role in , enabling the of bound solutes across endothelial barriers such as the blood-brain barrier and walls. This vectorial movement occurs via vesicular shuttling from the luminal to the abluminal surface, bypassing lysosomal degradation in some cases and allowing passage of macromolecules like cationized proteins into the . Such is particularly relevant in endothelial cells, where negative charges on both plasma membrane faces and the support the directed flux of polycations.

Macropinocytosis

Macropinocytosis is a subtype of pinocytosis characterized by the formation of large intracellular vesicles known as macropinosomes, which typically range from 0.2 to 5 μm in diameter, through the extension and retraction of actin-driven membrane protrusions such as ruffles or lamellipodia. This process enables cells to engulf substantial volumes of and solutes in a non-selective manner, distinguishing it as a bulk uptake mechanism. Initiation of macropinocytosis often occurs via signaling from receptor tyrosine kinases, such as those activated by (EGF) or colony-stimulating factor 1 (CSF-1), which promote polymerization and membrane dynamics. Pathogens, including certain viruses, can also trigger this pathway to facilitate entry into host cells. In biological contexts, macropinocytosis supports nutrient scavenging in Ras-transformed cancer cells, where it allows uptake of extracellular proteins for supply under nutrient-limited conditions, as seen in pancreatic ductal adenocarcinoma. Additionally, it enables antigen sampling in dendritic cells, permitting the constitutive internalization of soluble for immune and . Recent studies also highlight its role in promoting through autophagy-independent protein degradation in pancreatic tumors. Following formation, macropinosomes may mature and fuse with lysosomes, leading to the degradation of internalized contents through hydrolytic enzymes, or undergo partial of membrane components back to the plasma membrane to maintain cellular . Unlike constitutive fluid-phase pinocytosis, which operates continuously with smaller vesicles, macropinocytosis is typically induced by specific signals, resulting in selective activation despite its non-discriminatory cargo uptake. This -dependent process briefly involves branched networks mediated by proteins like Rac1 and Arp2/3 to drive ruffle closure.

Mechanism

General Steps

Pinocytosis involves the non-specific uptake of and dissolved solutes through the formation and internalization of membrane-bound vesicles, a common to various cell types. This mechanism follows a series of sequential stages that enable the plasma membrane to engulf and sequester external material into the . While the precise morphology varies across pinocytosis subtypes, the core steps provide a template for vesicle generation and processing. The process initiates with the or protrusion of the plasma membrane, creating pockets that surround . In many cases, this involves the formation of small depressions or extensions, such as ruffles in macropinocytosis, which trap solutes within the developing enclosure. Next, the open-ended closes to enclose the fluid, forming a nascent vesicle bounded by the plasma membrane. This sealing step captures the extracellular contents in a topologically distinct compartment ready for detachment. The vesicle then undergoes pinch-off and scission from the plasma membrane, fully releasing it into the as an independent structure. This separation completes the internalization phase, yielding vesicles typically ranging from 0.1 to 5 μm in diameter depending on the subtype. Following internalization, the vesicle traffics intracellularly to early endosomes or lysosomes, where its contents are sorted or processed. This movement integrates the pinocytosed material into the endocytic pathway for subsequent cellular handling. These stages have been visualized using electron microscopy, which reveals characteristic flask-shaped pits and vesicle profiles at the plasma membrane during and scission. Tracers like enhance contrast to track fluid entry in fixed samples.

Molecular Components

Pinocytosis involves a variety of molecular components that facilitate the and fission of the plasma membrane to form intracellular vesicles. Central to this process is the , which provides the structural framework and contractile force necessary for membrane deformation. polymerization drives the protrusion and ruffling of the membrane, particularly in fluid-phase and macropinocytic variants, enabling the enclosure of . , as -based motor proteins, contribute to membrane contraction and vesicle propulsion; for instance, myosin I isoforms in Dictyostelium discoideum are essential for pinosome internalization during fluid-phase uptake, with double mutants exhibiting defects in acquisition under suspension conditions. Similarly, myosin VI supports endocytic membrane dynamics in mammalian cells, linking networks to sites of vesicle formation. Phosphoinositides, particularly (PI(4,5)P₂), play a critical role in recruiting effector proteins to the plasma membrane during pinocytosis. Enriched at the inner leaflet, PI(4,5)P₂ binds and activates proteins involved in actin nucleation and membrane curvature, such as the , thereby coordinating cytoskeletal remodeling with vesicle budding. This lipid's or redistribution can trigger downstream signaling that sustains pinocytic activity, as seen in clathrin-independent pathways where PI(4,5)P₂ facilitates rapid without coat proteins. Vesicle scission in pinocytosis often relies on , a large that assembles into helical polymers around the neck of forming vesicles to mediate fission through GTP hydrolysis-induced constriction. While is prominently involved in clathrin-mediated , it also participates in certain clathrin-independent pinocytic processes. In platelets, inhibition reduces fluid-phase pinocytosis, highlighting its role in generating signaling for vesicle release. Class II phosphoinositide 3-kinase enzymes, specifically PI3K-C2α and PI3K-C2β, generate 3-phosphate (PI3P) and other signaling lipids that regulate pinocytic membrane trafficking. These kinases localize to the plasma membrane and endosomes, where PI3K-C2α promotes clathrin-dependent pinocytosis by enhancing recruitment, while PI3K-C2β supports actin-dependent membrane ruffling in vascular endothelial cells. Their differential activities ensure efficient fluid uptake, with knockdown studies showing reduced pinocytic rates without affecting other endocytic routes. Pinocytosis can proceed via both clathrin-dependent and clathrin-independent mechanisms. While depends on coats for cargo selection and budding, clathrin-independent forms of pinocytosis, such as macropinocytosis, rely instead on lipid-driven curvature and cytoskeletal forces for vesicle formation. This distinction allows constitutive fluid-phase uptake across diverse cell types, compensating for the absence of clathrin lattices through alternative scission mechanisms.

Energy Requirements and Regulation

ATP Dependence

Pinocytosis constitutes an active form of that relies on the of ATP to facilitate membrane invagination, curvature, and subsequent vesicle budding from the plasma membrane. This energy-intensive process powers the deformation of the and the recruitment of accessory proteins essential for vesicle formation, distinguishing it from mechanisms. Seminal studies in mouse macrophages have established that ATP serves as the currency, with depletion leading to a near-complete cessation of vesicle production. Cellular ATP for pinocytosis is generated through both and , reflecting the metabolic flexibility of cells like fibroblasts and macrophages. In these systems, inhibition of with , combined with glycolytic blockers such as iodoacetate or 2-deoxyglucose, drastically impairs ATP levels and reduces pinocytic vesicle formation by 80-90%, as measured by uptake of neutral markers like or . For instance, in cultured fibroblasts, such combined metabolic inhibition lowers activity to 10-20% of control rates, underscoring the dual reliance on aerobic and anaerobic pathways. Similarly, experiments in macrophages demonstrate that respiratory inhibitors alone, like or , suppress vesicle formation to low levels, while uncouplers of such as further confirm ATP's indispensable role. Direct evidence from ATP depletion experiments highlights the process's sensitivity to energy availability. In both macrophages and fibroblasts, conditions inducing ATP exhaustion—such as prolonged exposure to metabolic poisons—halt pinocytosis entirely, with no observable vesicle budding under electron microscopy. This arrest occurs rapidly, within minutes of ATP levels dropping below critical thresholds, emphasizing the process's strict energy dependence. ATP also supports ion pumps, notably the , which maintains the electrochemical required for efficient dynamics during pinocytosis.

Inhibitors and Regulators

Pinocytosis, particularly macropinocytosis, is modulated by various inhibitors that target key molecular processes involved in vesicle formation and dynamics. 5-(N-Ethyl-N-isopropyl)amiloride (EIPA), a selective inhibitor of the Na+/H+ exchanger, blocks macropinocytosis by preventing the submembranous alkalinization necessary for -driven ruffling and vesicle closure. Cytochalasin D, an filament disruptor, inhibits pinocytosis by interfering with cytoskeletal rearrangements required for in fluid-phase and adsorptive uptake pathways, as demonstrated in macrophage-like cells where it reduces fluid-phase pinocytosis rates without affecting baseline in all contexts. Wortmannin, a potent inhibitor of phosphoinositide 3-kinase (PI3K), suppresses macropinocytosis by disrupting the lipid signaling essential for recruiting regulatory proteins to the plasma , thereby halting vesicle formation in hepatic stellate cells during collagen endocytosis. Several regulators positively or negatively influence pinocytic activity. Amino acids, such as glutamic and aspartic acids, stimulate pinocytosis in mouse peritoneal macrophages by enhancing fluid-phase uptake rates through mechanisms independent of neutral or basic amino acids. Calcium ions regulate pinocytic membrane permeability and vesicle fusion; elevated extracellular Ca2+ levels promote cation-induced pinocytosis in amoebae by modulating actomyosin contraction and membrane flow, a process conserved in higher eukaryotic cells. Growth factors like epidermal growth factor (EGF) activate receptor tyrosine kinases (RTKs), triggering macropinocytosis in epithelial cells such as MCF-7 and A431 lines through Rac1-dependent signaling that drives membrane protrusion and solute uptake. The environment exerts significant control over pinocytic subtypes. In experimental settings, EIPA is widely employed due to its selectivity for macropinocytosis; it inhibits uptake in macropinosomes without perturbing clathrin-mediated of , allowing researchers to dissect macropinocytic contributions in scavenging and entry. Certain pharmacological agents paradoxically induce excessive pinocytosis leading to . Dual /mTORC2 inhibitors, such as OSI-027, trigger catastrophic macropinocytosis in cancer cells like rhabdomyosarcoma lines by deregulating sensing and lysosomal overload, resulting in non-apoptotic cell demise independent of other endocytic routes.

Biological Significance

Cellular Functions

Pinocytosis plays a crucial role in maintaining cellular by facilitating the non-selective uptake of and its dissolved components, which supports scavenging, immune surveillance, and intracellular balance. This process allows cells to sample their microenvironment, internalizing solutes and macromolecules that can be processed for metabolic needs or signaling. In physiological contexts, pinocytosis contributes to adaptive responses in diverse cell types, from epithelial barriers to immune effectors, ensuring efficient resource utilization and without relying solely on receptor-mediated pathways. In nutrient-poor environments, pinocytosis enables cells to acquire essential nutrients such as , sugars, and ions through the bulk internalization of . For instance, macropinocytosis, a prominent form of pinocytosis, allows cells like fibroblasts and epithelial cells to engulf proteins from the surroundings, which are then degraded in lysosomes to release for protein synthesis and energy production. This mechanism is particularly vital in conditions of , where traditional transporters may be insufficient, providing a flexible alternative for metabolic sustenance. Although direct uptake of free sugars and ions occurs less selectively via fluid-phase sampling, it supplements carrier-mediated transport by capturing dissolved extracellular concentrations proportional to their availability. In immune cells such as macrophages and dendritic cells, pinocytosis supports by enabling fluid-phase sampling of the extracellular milieu for detection. Macrophages utilize constitutive macropinocytosis to internalize soluble antigens, such as ovalbumin, which are trafficked to compartments for to T cells, enhancing adaptive immunity. Similarly, dendritic cells rely on actin-driven membrane ruffles to capture antigens like via macropinocytosis, directing them to MHC class II-positive lysosomes; this process is regulated by small like Rac1 and Cdc42, allowing efficient surveillance of potential threats in tissues. Such sampling ensures timely immune activation without specific receptor engagement. Pinocytosis is integral to transcytosis, the vectorial transport of molecules across epithelial barriers, exemplified by the uptake and transfer of (IgG) in the neonatal intestine. Fluid-phase pinocytosis initiates this process in intestinal epithelial cells, where IgG from maternal is non-selectively internalized into endosomes; there, it binds the neonatal (FcRn) at acidic , protecting it from degradation and directing its to the basolateral side for release into the bloodstream at neutral . This mechanism delivers to newborns, providing protective antibodies against infections during early development when endogenous production is limited. In podocytes, pinocytosis maintains glomerular by clearing excess components, preventing accumulation that could impair . Podocytes employ clathrin-independent pinocytosis to internalize filtered proteins and solutes from the subpodocyte space, trafficking them to lysosomes for degradation and thus preserving the of the glomerular barrier. This clearance function is essential for , as it regulates intracapillary and solute balance, supporting overall without compromising the selective permeability of the slit diaphragm. Pinocytosis contributes to cellular volume regulation by balancing fluid influx with subsequent , preventing osmotic imbalances during environmental fluctuations. Under hypertonic conditions, which cause cell shrinkage, increases to internalize and ions, aiding volume recovery; pinocytosis can internalize fluid equivalent to up to 25% of the cell volume. In hypotonic conditions causing swelling, predominates to manage tension and prevent rupture, though in specific cell types such as macrophages, may also increase as part of regulatory volume decrease. This dynamic interplay ensures long-term , as coordinated endo- and maintain surface area integrity.

Pathological Roles

Pinocytosis, particularly its macropinocytic form, plays a prominent pathological role in cancer by enabling nutrient scavenging in nutrient-poor tumor microenvironments. In KRAS-mutant cancers such as pancreatic ductal adenocarcinoma, where over 90% of cases harbor activating KRAS mutations, macropinocytosis facilitates the bulk uptake and lysosomal degradation of extracellular proteins like albumin, providing amino acids to fuel tumor growth and survival under metabolic stress. This process is driven by oncogenic signaling through pathways involving PI3K, Rac1, and Pak1, which promote membrane ruffling and vesicle formation, and is upregulated in other malignancies including lung, colorectal, and glioblastoma. Dysregulated macropinocytosis also contributes to therapeutic resistance; for instance, in multidrug-resistant cancer cells, it protects P-glycoprotein function by internalizing and recycling the efflux pump, reducing drug efficacy. Therapeutically, inhibitors like 5-(N-ethyl-N-isopropyl)amiloride (EIPA) suppress macropinocytosis and attenuate tumor progression in preclinical models of KRAS-driven pancreatic cancer. As of 2025, pinocytosis inhibitory nanoparticles have been developed to enhance delivery of immune checkpoint inhibitors like anti-PD-1 antibodies to solid tumors, improving efficacy while minimizing toxicity. Excessive pinocytosis can lead to methuosis, a non-apoptotic characterized by massive vacuolization from unfused macropinosomes that displace and cause rupture, representing both a pathological outcome and a potential cancer therapy target. In and Ras-transformed cells, hyperstimulation of macropinocytosis by oncogenic H-Ras triggers methuosis through impaired vesicular volume regulation and ion transport defects, such as dysfunction in or ClC-3 channels, preventing shrinkage. Compounds like MOMIPP and CX-5011 induce methuosis selectively in cancer cells by activating JNK signaling and blocking lysosomal fusion, showing promise in preclinical studies for , , and brain cancers without affecting normal cells. Beyond , pinocytosis contributes to in cardiovascular and neurological disorders. In , receptor-independent macropinocytosis in macrophages drives formation by enabling rapid uptake of unmodified (LDL), promoting lipid accumulation in arterial walls and plaque progression; inhibition of this process with drugs like reduces lesion development in hypercholesterolemic mouse models. In neurological contexts, mutations in Na+/H+ exchangers (NHE6, NHE7, NHE9) disrupt pinocytic , leading to and contributing to syndromes like Christianson syndrome and . Additionally, P2Y4 receptor-mediated pinocytosis in facilitates amyloid-beta uptake, exacerbating in . In lysosomal storage diseases such as Gaucher's and Niemann-Pick, defective impairs pinosome maturation, causing vesicle swelling and substrate accumulation that drives cellular .

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK26870/
  2. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/pinocytosis
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC4174540/
  4. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/pinocytosis
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC9918140/
  6. https://www.ncbi.nlm.nih.gov/books/NBK9831/
  7. https://www.osmosis.org/answers/pinocytosis
  8. https://rupress.org/jcb/article/68/3/665/18652/Membrane-flow-during-pinocytosis-A-stereologic
  9. https://www.etymonline.com/word/pinocytosis
  10. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.651982/full
  11. https://www.oed.com/dictionary/pinocytosis_n
  12. https://www.collinsdictionary.com/us/dictionary/english/pinocytosis
  13. https://www.merriam-webster.com/dictionary/pinocytosis
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC6738810/
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC4292149/
  16. https://www.nasonline.org/wp-content/uploads/2024/06/lewis-warren-h.pdf
  17. https://www.sciencedirect.com/science/article/pii/S2667290121000474
  18. https://www.youtube.com/watch?v=7qUCTgJ8C8s
  19. https://link.springer.com/article/10.1007/BF02913945
  20. https://rupress.org/jcb/article/8/3/675/10404/AN-ELECTRON-MICROSCOPIC-STUDY-OF-PINOCYTOSIS-IN
  21. https://doi.org/10.1208/s12248-008-9055-2
  22. https://www.cell.com/current-biology/fulltext/S0960-9822(21)00069-5
  23. https://doi.org/10.3389/fendo.2017.00261
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC1782244/
  25. https://elifesciences.org/articles/83712
  26. https://www.pnas.org/doi/10.1073/pnas.1524532113
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC7840718/
  28. https://pubmed.ncbi.nlm.nih.gov/7774602/
  29. https://pubmed.ncbi.nlm.nih.gov/8522584/
  30. https://pubmed.ncbi.nlm.nih.gov/19088799/
  31. https://portlandpress.com/biochemj/article/479/21/2311/232084/PI-4-5-P2-signaling-the-plasma-membrane
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC7501565/
  33. https://www.sciencedirect.com/science/article/pii/S0006291X24007861
  34. https://pubmed.ncbi.nlm.nih.gov/30374841/
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC4031960/
  36. https://www.sciencedirect.com/science/article/pii/0955067495800158
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC2138244/
  38. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2109356/
  39. https://pubmed.ncbi.nlm.nih.gov/5950886/
  40. https://pubmed.ncbi.nlm.nih.gov/15564133/
  41. https://pubmed.ncbi.nlm.nih.gov/25080486/
  42. https://rupress.org/jem/article/125/2/213/21676/THE-REGULATION-OF-PINOCYTOSIS-IN-MOUSE-MACROPHAGES
  43. https://pubmed.ncbi.nlm.nih.gov/23195319/
  44. https://pubmed.ncbi.nlm.nih.gov/17502486/
  45. https://www.science.org/doi/10.1126/scitranslmed.add2376
  46. https://www.pnas.org/doi/10.1073/pnas.1911393116
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC6304737/
  48. https://doi.org/10.1016/j.cell.2015.06.017
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC7463864/
  50. https://doi.org/10.3390/membranes10080177
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC12049489/
  52. https://doi.org/10.1038/s41467-025-59447-1
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC8866310/
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC8715248/
  55. https://doi.org/10.1016/j.bpj.2021.11.019
  56. https://doi.org/10.1038/nature12138
  57. https://doi.org/10.1038/nature12113
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC12186146/
  59. https://doi.org/10.1007/s10495-014-0989-2
  60. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1534217/full
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC3811894/
  62. https://doi.org/10.1038/nrm3255
Add your contribution
Related Hubs
User Avatar
No comments yet.